AHCO

SkyKnight Capital Fund II, L.P.

Known title: DirectorCIK: 0001748212

SkyKnight Capital Fund II, L.P.'s purchase track record

How the stock did after each of SkyKnight Capital Fund II, L.P.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
6
of 6 since March 4, 2022
Stock higher 6 months later
100%
3 months: 100%
Median 6-month return
+25.9%
3 months: +15.4%
Beat the S&P 500
100%
median +26.8% vs. index
PurchaseStockAmount3 months6 months
6/9/2022AHCO$1.96M+8.8%+25.3%
6/1/2022AHCO$616K+1.8%+26.4%
5/20/2022AHCO$3.63M+20.7%+21.4%
5/12/2022AHCO$3.16M+49.1%+45.4%
3/14/2022AHCO$381K+12.1%+29.1%
3/4/2022AHCO$471K+18.8%+16.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.

this person other insiders at AHCO

Transaction History

AHCO▲ Buy$1.7M
AHCO▲ Buy$138K
AHCO▲ Buy$105K
AHCO▲ Buy$616K
AHCO▲ Buy$4K
AHCO▲ Buy$1.7M
AHCO▲ Buy$162K
AHCO▲ Buy$1.7M
AHCO▲ Buy$350K
AHCO▲ Buy$1.6M
AHCO▲ Buy$851K
AHCO▲ Buy$364K
AHCO▲ Buy$381K
AHCO▲ Buy$271K
AHCO▲ Buy$200K

We use analytics to understand how market-wall is used. No personal data is sold.